Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2024 Earnings Call Transcript August 6, 2024
Harmony Biosciences Holdings, Inc. beats earnings expectations. Reported EPS is $0.553, expectations were $-0.04.
Operator: Good morning. My name is Todd, and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony Biosciences’ Second Quarter 2024 Financial Results Conference Call. All participant lines have been placed on mute to prevent any background...
